Tirzepatide: tested on its own
147 studies: no other medicine in its arm. Page 2 of 2. Open to participants first (79), then studies with results posted, then the rest; newest registration first within each.
- A Study of Tirzepatide in Chinese Participants With Type 2 Diabetes MellitusCompletedNCT04235959Phase 1Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Participants With Obesity or OverweightCompletedNCT04184622Phase 3Results postedReport a problem
- A Study of the Effect of Tirzepatide on How the Body Handles Birth Control Pills in Healthy Female ParticipantsCompletedNCT04172987Phase 1Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)CompletedNCT04166773Phase 2Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes on Metformin With or Without Sulfonylurea (SURPASS-AP-Combo)CompletedNCT04093752Phase 3Results postedReport a problem
- A Study to Measure Energy Expenditure and Food Intake in Participants With Obesity Using TirzepatideCompletedNCT04081337Phase 1Results postedReport a problem
- A Study of Tirzepatide at Different Injection Sites in Participants With Different Body SizesCompletedNCT04050670Phase 1Results postedReport a problem
- A Study of Tirzepatide in Participants With Type 2 Diabetes MellitusCompletedNCT04050553Phase 1Results postedReport a problem
- A Study of Tirzepatide (LY3298176) Versus Placebo in Participants With Type 2 Diabetes Inadequately Controlled on Insulin Glargine With or Without MetforminCompletedNCT04039503Phase 3Results postedReport a problem
- A Study of Tirzepatide Administered by Two Different Devices in Healthy ParticipantsCompletedNCT04004988Phase 1Results postedReport a problem
- A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 DiabetesCompletedNCT03987919Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes Not Controlled With Diet and Exercise AloneCompletedNCT03954834Phase 3Results postedReport a problem
- A Study of Tirzepatide in Participants With Type 2 Diabetes Mellitus (T2DM)CompletedNCT03951753Phase 1Results postedReport a problem
- A Study of Tirzepatide in Participants With Impaired Liver FunctionCompletedNCT03940742Phase 1Results postedReport a problem
- A Study of Tirzepatide (LY3298176) Versus Insulin Degludec in Participants With Type 2 DiabetesCompletedNCT03882970Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) Compared to Dulaglutide in Participants With Type 2 DiabetesCompletedNCT03861052Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) Once a Week Versus Insulin Glargine Once a Day in Participants With Type 2 Diabetes and Increased Cardiovascular RiskCompletedNCT03730662Phase 3Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Participants With Impaired Kidney FunctionCompletedNCT03482024Phase 1Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Healthy ParticipantsCompletedNCT03375463Phase 1Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Japanese Participants With Type 2 DiabetesCompletedNCT03322631Phase 1Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 DiabetesCompletedNCT03311724Phase 2Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes MellitusCompletedNCT03131687Phase 2Results postedReport a problem
- A Study of Tirzepatide (LY3298176) in Healthy Participants and Participants With Type 2 Diabetes (T2DM)CompletedNCT02759107Phase 1Results postedReport a problem
- An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use DisorderActive, not recruitingNCT07693608Phase 2Report a problem
- A Study of Tirzepatide (LY3298176) in Adult Participants in India With Either Type 2 Diabetes Mellitus or ObesityActive, not recruitingNCT07438444Phase 4Report a problem
- A Study to Evaluate the Effect of Fasting Duration and Tirzepatide Withholding on the Amount of Food and Fluid in the Stomach in Participants With Type 2 Diabetes Mellitus and Participants With Overweight or Obesity Without Type 2 Diabetes MellitusActive, not recruitingNCT07299084Phase 1Report a problem
- The Long COVID Treatment TrialActive, not recruitingNCT07128082Phase 2Report a problem
- A Long-Term Study of Tirzepatide (LY3298176) in Adults With Type 1 Diabetes and Obesity or OverweightActive, not recruitingNCT06962280Phase 3Report a problem
- Effects of Tirzepatide on Weight Loss and Chronic Inflammation in People With HIVCompletedNCT06935838Phase 2Report a problem
- Efficacy and Safety of Tirzepatide for Weight ManagementActive, not recruitingNCT06918405Phase 3Report a problem
- A Study of Tirzepatide (LY3298176) Compared With Placebo in Adults With Type 1 Diabetes and Obesity or OverweightActive, not recruitingNCT06914895Phase 3Report a problem
- Effect of Tirzepatide on Brown Adipose Tissue in ObesityCompletedNCT06893211Phase 2Report a problem
- A Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)Active, not recruitingNCT06864026Phase 4Report a problem
- GLP-1s to Enhance Lasting Optimal WeightActive, not recruitingNCT06861439Phase 4Report a problem
- Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) PatientsActive, not recruitingNCT06774079Phase 4Report a problem
- A Study of a Weight Loss Intervention in People With Endometrial CancerActive, not recruitingNCT06751589Early Phase 1Report a problem
- Tirzepatide for Obesity and Meth Use DisorderCompletedNCT06745128Phase 2Report a problem
- Randomized Control Trial of Sleeve Gastrectomy With Tirzepatide in Maximizing Weight LossActive, not recruitingNCT06734273Early Phase 1Report a problem
- A Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During RamadanCompletedNCT06635057Phase 4Report a problem
- Subcutaneous Tirzepatide Once-weekly in Patients With Obesity and Knee Osteoarthritis (STOP KNEE-OA)Active, not recruitingNCT06191848Phase 4Report a problem
- GLP-1 Receptor Agonists Post-Bariatric Surgery (GRABS) Pilot TrialActive, not recruitingNCT06162715Phase 2/3Report a problem
- A Study of Tirzepatide (LY3298176) Once Weekly in Adolescent Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesActive, not recruitingNCT06075667Phase 3Report a problem
- A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related ComorbiditiesCompletedNCT06047548Phase 3Report a problem
- A Study of Investigational Tirzepatide (LY3298176) Doses in Participants With Type 2 Diabetes and ObesityActive, not recruitingNCT06037252Phase 2Report a problem
- Effects of Tirzepatide Plus Intensive Lifestyle Therapy on Body Weight and Metabolic Health in Latinos With ObesityWithdrawnNCT06009653Phase 4Report a problem
- A Study of Tirzepatide (LY3298176) on the Reduction on Morbidity and Mortality in Adults With ObesityActive, not recruitingNCT05556512Phase 3Report a problem
- A Study of Tirzepatide (LY3298176) in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 DiabetesCompletedNCT05536804Phase 2Report a problem